Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on June 2, 2025
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
GlobeNewswire
·
June 2, 2025
LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) 2.8 million injections of repackaged off-label bevacizumab in Europe each year1 ISELIN, N.J., …
Aura Minerals Agrees to Acquire the Mineração Serra Grande Gold Mine in Goiás, Brazil
GlobeNewswire
·
June 2, 2025
ROAD TOWN, British Virgin Islands, June 02, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce that Aura, AngloGold Ashanti plc (“AngloGold”) and a wholly owned subsidiary of …
NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-291 in Spinal Cord Injury
GlobeNewswire
·
June 2, 2025
Study met its primary endpoint by achieving statistical significance on one of its two pre-specified co-primary endpoints, demonstrating increased electrical connectivity between the brain and hand muscle in individuals with a cervical level spinal cord …
Cancer mRNA Vaccine Clinical Trials FDA Approval mRNA Therapies Clinical Advances Insight
GlobeNewswire
·
June 2, 2025
Delhi, June 02, 2025 (GLOBE NEWSWIRE) -- mRNA cancer vaccines approach clinical maturity, the commercial landscape surrounding them is rapidly changing. Over 60 candidates in the works, with a few in Phase III clinical trials, the industry is increasingly …
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
GlobeNewswire
·
June 2, 2025
Deucrictibant data shows single-dose durability without symptom reoccurrence in the majority of HAE attacks treated First-ever bradykinin B2 receptor mechanism-on-mechanism prophylactic/on-demand data supports potential for deucrictibant portfolio …
First Atlantic Nickel to Attend Benchmark Mineral Intelligence's GIGA USA 2025 Conference, Highlighting Atlantic Nickel Project’s Smelter-Free Processing for North America’s Critical Minerals Supply Chain
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) (“First Atlantic” or the “Company”) is pleased to announce its participation at the Benchmark Mineral Intelligence GIGA USA …
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
GlobeNewswire
·
June 2, 2025
Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinic Combined …
Shoqan School, founded by Kenges Rakishev and Aselle Tasmagambetova, Lists One-Billion-Tenge Bond on KASE, a First for Kazakh Schools
GlobeNewswire
·
June 2, 2025
ALMATY, Kazakhstan, June 02, 2025 (GLOBE NEWSWIRE) -- Shoqan School, founded by Kenges Rakishev and Aselle Tasmagambetova, has become the first educational organization in Kazakhstan to issue bonds, which in this case will be used to support the …
PONY AI Inc. Reaches Strategic Partnership with Xihu Group for Robotaxi Deployment in Shenzhen
GlobeNewswire
·
June 2, 2025
SHENZHEN, China, June 02, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced a strategic partnership with Shenzhen Xihu …
Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
GlobeNewswire
·
June 2, 2025
MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today announces the appointment of Louise …
DXN Limited (DXN.AX) Contract Signed for A$4.6 Million Modular Data Centre Deployment in Hawaii
ABN Newswire
·
June 2, 2025
Sydney, June 2, 2025 AEST (ABN Newswire) - DXN Limited (ASX:DXN), a specialist in prefabricated modular data centre solutions, is pleased to announce the signing of a contract with Globalstar Inc (Globalstar) valued at approximately AU$4.6 million. Key …
Lithium Universe Ltd (LU7.AX) Spodumene Offtake Update
ABN Newswire
·
June 2, 2025
SPODUMENE SUPPLY DISCUSSIONS FOR BECANCOUR LITHIUM REFINERY Melbourne, June 2, 2025 AEST (ABN Newswire) - Lithium Universe Limited (ASX:LU7) (KU00:FRA) (LUVSF:OTCMKTS) is pleased to provide an update of its project development since the launch of the …